| Top Adding |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Land > Rise in Rural Land for Sale Prices in UK - An Analysis of Forces Driving it |
|
Top Adding - Rise in Rural Land for Sale Prices in UK - An Analysis of Forces Driving it
Prices in UK land for sale are showing an upward trend for past few years. This rise is particularly According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product sharp in city suburbs, towns and farmlands. According to Guardian, the price of farmland has risen ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in by 9% in the last year itself. A recent report by Royal Institution of Chartered Surveyors (RICS) fo lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. nd that the average cost of a hectare of farmland now stands at ?7,389 (?3,066 an acre) - up from ?5 here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe 759 (?2,330 an acre) at the start of 2004. About half of the land that changed hands during April 1 d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro o June 30 was snapped up by "non-farmer individuals". So what are the causes of this sharp rise in ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc land for sale prices? In our view an array of factors are driving this price rise; most prominent a easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ong them are: •In UK many city dwellers are increasingly opting to live outside congested city envi nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically onment and are looking to realize that dream of owning their own little smallholding in the countrys and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ de. According to RICS spokeswoman Sue Steer. "That sort of rural idyll is quite appealing to a lot o ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi people." • There are also people wanting to buy pastures and farmhouses which also enables them to ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a get tax relief (although there have been a recent government crackdown on it). • Land banking firm dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod are increasingly becoming popular in UK and abroad enabling small investors to acquire small pieces cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin of farmlands for investments purposes. This has led to a surge in investments in UK farmlands. The p tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen oliferation of "land banking" firms selling small plots of farmland to investors at thousands of pou t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ds a pop are testament to the fact that a great many people have bought into the old saying that "th ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ey don't make land any more". All these factors have combined to produce a surge in prices of UK fa y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products mlands which is expected to gain strength in coming times. Also with coming Olympics in 2012 the pri . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de es are expected to increase even further especially in areas surrounding London. Thus investments in elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip UK Land are likely to remain a prominent investment for enterprising investors in both UK and abroad tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Starting an Arcade Business: It's Fun, Entertaining, and Profitable! What's the Difference Between Successful Businesses and Struggling Businesses?
|